Atlas Trials

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Clinical trial NCT07463313 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07463313
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Thymoma and Thymic Carcinoma
Start date
2026-03-01
Primary completion
2029-03-01
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.